Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Trial with nasal calcitonin concludes successfully

Dec. 21, 2000

Improved compositions of LHRH or somatostatin analogues described in recent patent

Dec. 20, 2000

Shearwater to pegylate Regeneron's obesity Rx

Dec. 20, 2000

Phase III general surgery trial demonstrates significant benefits for Oxygent

Dec. 20, 2000

Novel Yamanouchi compound activates gene expression, translocation of Glut4

Dec. 18, 2000

AeroGen begins phase II clinical trials with AeroDose insulin inhaler

Dec. 18, 2000

Potential new contraceptive agents patented by Schering

Dec. 15, 2000

FDA requests additional data to support Dynepo BLA

Dec. 15, 2000

AHP and Ligand report preparation and use of new progesterone receptor modulators

Dec. 14, 2000

Japanese research team discovers new PTP inhibitors for diabetes

Dec. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
SKL-35501 shows broad antitumor activity in solid tumors
BioWorld Science
Neurotensin receptor 1 (NTSR1) is overexpressed in several aggressive solid tumors, including colorectal and pancreatic cancer, making it a promising therapeutic...